To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

ATP Assay Market

ATP Assay Market Analysis By Component (Consumables & Accessories, Instruments), By Application (Contamination Testing, Disease Testing, Drug Discovery & Development), By End User (Pharmaceutical & Biotechnology Companies, F&B Companies & Other), By Region - Global Market Insights 2022 to 2027

Analysis of ATP Assay market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

ATP Assay Market Outlook (2022-2027)

The global ATP assay market is predicted to evolve at a CAGR of 7% and increase from a market valuation of US$ 310 million in 2022 to US$ 435 million by the end of 2027.

Sales of consumables & accessories are forecasted to accelerate at a CAGR of 7.2% through 2027 due to the expanding use of ATP assays to check for microbial contamination in food & beverage, pharmaceutical, and healthcare industries.

Report Attributes

Details

ATP Assay Market Size (2022)

US$ 310 Million

Projected Market Value (2027)

US$ 435 Million

Global Market Growth Rate (2022-2027)

7% CAGR

Market Share of Consumables & Accessories

85%

Share in Diagnostic Enzyme Market (2022)

8%

Key Companies Profiled

  • BioThema AB
  • Biotium
  • BioVision, Inc.
  • 3M Company
  • AAT Bioquest, Inc.
  • Abcam PLC.
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Canvax Biotech S.L.
  • Creative Bioarray

Don't Need a Global Report?

Save 40% on Country & Region specific reports

Demand Analysis of ATP Assays (2017-2021) Vs. Market Estimates (2022-2027)

“Rising Need to Evaluate Safety of Pharmaceuticals Driving Demand for ATP Assays”

According to Fact.MR, a market research and competitive intelligence provider, the ATP assay market is projected to increase at a CAGR of 7% from 2022 to 2027.

Adenosine triphosphate, or ATP, is the main energy source that all living organisms have by nature. Cell viability is influenced by ATP, and the more ATP there is in a system, the more live cells there are. ATP assays are highly successful at identifying the development of bacteria and other microorganisms by detecting cell viability and examining the microbiological content of living things.

The most well-known detection techniques are ATP assays that are bioluminescent, fluorescent, and colorimetric. Because of its increased sensitivity, streamlined procedure, homogeneous protocol, and quicker findings, bioluminescent ATP tests are the most effective. These assays are widely used in the life sciences and healthcare sectors to evaluate the safety of pharmaceuticals.

The employment of advanced technologies in microbial detection, increased demand for cell-based assays in research, rising funding for cancer and stem cell research, and the high prevalence of chronic diseases are the main drivers of market growth.

ATP assay market forecast by Fact.MR

ATP Assay Market

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Which Market Elements are Boosting Demand for ATP Assays?

“Rapid Innovations in ATP Assay Probes”

Defining and comprehending ATP dynamics offers useful mechanistic insights into activities ranging from immune cell chemotaxis to neurotransmission. Therefore, a methodology is required to investigate the temporal and spatial aspects of ATP dynamics in living specimens, from the subcellular to the organismal levels.

There have been various ATP-specific molecular probes created in recent decades. These probes have been used in conjunction with imaging techniques, particularly optical microscopy, to make it possible to identify this important molecule both qualitatively and quantitatively.

Even though there are several ATP imaging tools available right now, ATP metabolism and signaling cannot yet be fully analyzed. The measurement of ATP content by first-generation ATP test methods is only semiquantitative because they are based on fundamental concepts. Specific second-generation methods and reagents are created to reduce a variety of interferences present in water applications, such as organics, biocides, dissolved solids, and suspended particles.

“Growing Awareness about Food Safety”

Several governments and organizations have issued laws setting acceptable amounts of pollutants, residues, and additives in food items to guarantee the highest quality products with the fewest health concerns. It lowers the possibility of closures, recalls, and diseases caused by contaminated food. It can also increase productivity and lower expenses.

One of the main global concerns is food contamination, which contributes to illnesses, fatalities, and other health issues. ATP tests are used in food manufacturing facilities to check the cleanliness of the surfaces that come into touch with the food.

It should conform to the safety and quality of the items and confirm that the surfaces are free of dangerous microbiological loads. The demand for ATP assays has increased as a result of growing concerns about food safety and the need to stop adulteration and maintain food quality.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

What Obstacles Might Market Players Encounter?

“High Cost & Several Drawbacks of ATP Bioluminescence Assays”

The usage of high-throughput screening equipment and high-content screening systems, as well as flow cytometers, is primarily reliant on the availability of such instruments. These systems are expensive because they have cutting-edge features and functionality.

Due to the requirement to uphold high standards, cell biology research is expensive. Furthermore, due to financial restrictions, purchasing these devices becomes challenging for small hospitals, diagnostic labs, and university and research labs.

The total cost of ownership of these instruments has increased as a result of the maintenance charges as well as several other indirect expenses. This is a significant barrier to the widespread use of the instruments needed for ATP assays.

The quick ATP bioluminescence assays' several drawbacks are anticipated to restrain market expansion over the coming years. These assays are not sensitive enough to detect spores and cannot easily distinguish ATP from microbes, plants, and mammals.

The ATP bioluminescence values are typically disturbed by luminescence from meals. Because of these reasons, many scientists think that ATP bioluminescence assays cannot completely replace the established microbiological analysis techniques.

The lack of skilled professionals and the inability to distinguish between extracellular and intracellular ATP are anticipated to limit market expansion.

How are Aspiring Market Players Contributing to Market Growth?

“New Market Entrants Focused on Implementing Innovative Technologies”

Everyone is at risk from the worldwide health problems caused by food contamination. Due to the rapidity and breadth of product distribution, local incidents can turn into urgent global emergencies. Every continent has significant outbreaks of food-borne illnesses, which are frequently exacerbated by international travel and tourism.

As a result, new companies are using innovative technologies to find and check food supply at different stages of distribution.

  • A start-up based in the U.S., SafeTraces uses DNA sequencing to create solutions for sanitation certification, safe airflow verification, and food and medicine traceability. saniDART is an ATP assay method approved by the Association of Analytical Chemists Research Institute for evaluating sanitation efficacy at the microbiological level. The solution provides the results in around 25 minutes and uses an indicator to track the eradication of pathogenic germs.

What Makes North America a Leading Regional Market for ATP Assays?

“Growing Demand for Cell-based Assays in Scientific Research in North America”

North America accounts for the highest share of the ATP assay market. Market growth is attributed to the robust pharmaceutical and biotechnology sectors, growing demand for cell-based assays in scientific research, rising awareness about food safety, and increased government support for life science research.

Due to factors, including rising disposable income, rising demand for cell proliferation assays, and the presence of renowned organizations in numerous industry verticals, North America is predicted to lead the market over the projection period.

Country-wise Insights

What is the Outlook of the U.S. ATP Assay Market?

“Increased Government Funding for R&D Programs”

The market in the U.S. is expanding significantly as a result of growing consumer awareness of the advantages offered by ATP and the increased prevalence of chronic diseases such as cancer.

The soaring demand for cutting-edge cell-based therapeutics, the expanding number of clinical and research laboratories, the appearance of highly advanced cell characterization assays, and increased government funding for R&D programs all contribute to market growth.

How is the Market for ATP Assays Progressing in China?

“Increasing Stem Cell Research Initiatives in China”

The ATP assay market in China is expected to increase at a CAGR of 11% from 2022 to 2027. Increasing stem cell research initiatives, medication discovery & development studies, and favorable regulatory standards are driving market growth.

Some of the main drivers influencing market expansion include expanding healthcare and food and beverage industries, rising research funding, rising investments by pharmaceutical and biotechnology businesses, and modernizing research infrastructure.

Category-wise Insights

Why are Consumables & Accessories Exhibiting High Demand?

“Growing Usage of Consumables & Accessories for Tumor Testing and Cell Proliferation”

Based on components, the ATP assay market is classified into consumables & accessories and instruments. Consumables & accessories account for 85% share of the global market.

The high prevalence of chronic diseases, which necessitate tumor testing and cell proliferation, the rise in drug development, and the frequent acquisition of consumables by biotechnology and pharmaceutical firms are all factors contributing to segment growth. Cell viability assays are widely used in research institutions.

Which Application is Anticipated to Lead Revenue Generation?

“Rising Adoption of Contamination Testing Techniques in Several Industries”

The ATP assay market is categorized into drug discovery & development, disease testing, and contamination testing on the basis of the application.

The contamination testing segment is expected to rise at a significant CAGR over the forecast period due to the increasing regulatory requirements of the food and beverage and pharmaceutical industries for clean production and the requirement for cleaning and sanitizing hospital environmental surfaces.

Due to the widespread usage of contamination testing techniques in the pharmaceutical, biotechnology, food and beverage sectors, as well as hospitals and diagnostic laboratories, the contamination testing segment is anticipated to account for the largest revenue share throughout the forecast period.

Which End User is Expected to Generate High Revenue for Market Players?

“Increase in Product Quality Control Attention by Pharmaceutical & Biotechnology Companies”

By end user, the ATP assay market is divided into F&B companies, academic & research institutions, hospitals & diagnostic laboratories, and pharmaceutical & biotechnology companies.

The presence of numerous pharmaceutical players, the booming pharmaceutical & biotechnology companies, an increase in pharmaceutical company attention to product quality control, and increased government support for R&D activities, are all factors that contribute to the largest share of the pharmaceutical and biotechnology segment.

The commercial growth of different pharmaceutical companies, the rising demand for gene and cell therapies for degenerative illnesses, and the growing use of cell-based assays for drug discovery are all factors that have contributed to segment growth.

Competitive Landscape

Key players in the ATP assay market are spending on R&D, brand development, and developing solid customer relationships to strengthen their competitive position.

For instance :

  • In 2021, the size of Abcam's immunoassay kit R&D and production facility in Eugene, Oregon, was doubled. This increased capacity is another step in Abcam's growth strategy in the U.S. and will help it fulfil its promise to serve the worldwide biopharmaceutical and research industries.

Key Segments Covered in ATP Assay Industry Research

  • By Component :

    • Consumables & Accessories
    • Instruments
  • By Application :

    • Contamination Testing
    • Disease Testing
    • Drug Discovery & Development
  • By End User :

    • Pharmaceutical & Biotechnology Companies
    • F&B Companies
    • Hospitals & Diagnostic Laboratories
    • Academic & Research Institutions
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

- Premium Report Details -

ATP Assay Market
  • FACT7745MR
  • Oct-2022
  • Healthcare
  • 170 Pages
  • 84 Tables
  • 112 Figures

- Let's Connect -

Talk To an Expert Today Connect

- Get Started -

Get insights that lead to new growth opportunities

Buy Now

Get A Special pricing for start-ups and universities

Enquiry Before Buying

- Humble, Yet Honored -

Our prestigious clients

- Research Methodology -

An Adaptive Approach to Modern-day Research Needs

Get Methodology

- FAQs -

Consumables & accessories account for 85% share of the global market.

Demand for ATP assays is anticipated to increase at 7% CAGR from 2022 to 2027.

The global ATP assay market is valued at US$ 310 million.

North America accounts for the highest share of the global ATP assay market.

BioThema AB, Biotium, and BioVision, Inc. are key providers of ATP assays.

Exclusive Report

Need An Exclusive Report For Your Unique Requirement?

Google translate